International Clinical Trial: Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial)

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07454980) titled 'Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial)' on Feb. 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: Jenscare Innovation Inc.

Condition: Tricuspid Regurgitation (TR)

Intervention: Device: TTVI with LuX-Valve Plus System

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: May 2026

Target Sample Size: 680

To know more, visit https://clinicaltrials.gov/study/NCT074549...